Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideELVElevance Health
FinDog View：Neutral
GILDGilead Sciences
FinDog View：Neutral
| Metric | ELV | GILD |
|---|
| Close | 420.07 | 170.68 |
| Market Cap | $90.8B | $213B |
| 1M | +8.04% | +14.51% |
| P/E (TTM) | 17.9 | — |
| Forward P/E | 14.0 | 22.0 |
| P/E 5-Yr Percentile | 66 | — |
| P/S | 0.5 | 7.0 |
| P/B | 2.1 | 17.9 |
| Dividend Yield | 1.24% | 3.98% |
| Latest Quarter Revenue | $51.4B | $8.3B |
| Revenue YoY | +1.4% | +6.8% |
| Gross Margin | 89.0% | 81.1% |
| Latest Quarter EPS | 6.27 | 1.94 |
| Avg Post-Earnings Move | ±3.8% | ±3.8% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 4.03% | 2.57% |
| 90-Day Net Insider Buying | −$4.7M | −$15.9M |
ELV · Revenue, Last 8 Quarters ($B)
GILD · Revenue, Last 8 Quarters ($B)
